Company Filing History:
Years Active: 2015
Title: Michael Wallner: Innovator in Hypoallergenic Molecules
Introduction
Michael Wallner is a notable inventor based in Salzburg, Austria. He has made significant contributions to the field of allergy research, particularly through his innovative work on hypoallergenic molecules. His dedication to improving the quality of life for allergy sufferers is evident in his patented inventions.
Latest Patents
Michael Wallner holds a patent for hypoallergenic molecules. The present invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia. This invention comprises mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v Ia. This patent highlights his commitment to advancing allergy treatment options.
Career Highlights
Michael Wallner is associated with Biomay AG, a company known for its innovative approaches in biotechnology. His work at Biomay AG has allowed him to focus on developing solutions that address the challenges faced by individuals with allergies. His expertise and research have positioned him as a key figure in the field.
Collaborations
Michael collaborates with esteemed colleagues such as Barbara Bohle and Martin Himly. Their combined efforts contribute to the advancement of research in hypoallergenic solutions and enhance the impact of their work in the scientific community.
Conclusion
Michael Wallner's contributions to the field of hypoallergenic molecules demonstrate his innovative spirit and commitment to improving health outcomes for allergy sufferers. His work at Biomay AG and his collaborations with other experts further solidify his role as a leading inventor in this important area of research.